Roche Could Pay $2B In Deal To Develop Potent Cancer Drugs
Moma Therapeutics announced Thursday that it could receive over $2 billion in milestone payments from Swiss pharmaceutical giant Roche through a new collaboration to develop powerful cancer treatments....To view the full article, register now.
Already a subscriber? Click here to view full article